<DOC>
	<DOCNO>NCT01602900</DOCNO>
	<brief_summary>This study investigate new experimental drug treat Huntington 's Disease get brain . If get brain study explore relationship amount drug brain amount drug blood . The study involve healthy male volunteer .</brief_summary>
	<brief_title>Healthy Volunteer Positron Emission Tomography ( PET ) Brain Occupancy Study Phosphodiesterase 4 ( PDE4 ) Inhibitor Huntington 's Disease</brief_title>
	<detailed_description>This open label , non-randomized , adaptive design PET occupancy study healthy adult male . The primary aim study describe relationship plasma concentration brain PDE4 occupancy GSK356278 time . Up 24 healthy volunteer may administer single dos GSK356278 order obtain 12 evaluable complete data set occupancy estimate . This study help optimize dose selection future clinical study GSK356278 .</detailed_description>
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Rolipram</mesh_term>
	<criteria>Healthy male volunteer , age 2255 year . Normal blood pressure , laboratory value , body mass index Willing agree study procedure &amp; contraception requirement Capable give write informed consent Any evidence disease would preclude participation clinical study ( include sexually transmit disease , exessive alcohol consumption , substance abuse ) . Previously involve another clinical trial within 3 month prior schedule administration study drug Smoker Suffers claustrophobia Any contraindication MRI scanning ( e.g . pacemaker , metal implant filling )</criteria>
	<gender>Male</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>